SEATTLE–(BUSINESS WIRE)–Kestra Medical Technologies is launching the ASSURE Clinician Experience (ACE), a program that lets electrophysiology and cardiology professionals wear and simulate use of the ASSURE® Wearable Cardioverter Defibrillator (WCD) system at The Heart Rhythm Society #HRX2023 global health and technology conference, September 21-23, 2023 in Seattle, WA. Clinicians that participate will be […]
Tag: Kestra Medical Technologies
ASSURE Wearable Cardioverter Defibrillator (WCD) System Earns 2022 Medical Design Excellence Award
ASSURE System Honored as One of the Year’s Best Designed Cardiovascular Devices KIRKLAND, Wash.–(BUSINESS WIRE)–Kestra Medical Technologies announced today that the company’s ASSURE® Wearable Cardioverter Defibrillator (WCD) system was recognized as one of the winners of the(MDEA), garnering honors in the Cardiovascular Devices category. The ASSURE® WCD system represents the next generation of monitoring and […]



